TrialDaily
Every weekday we read the day's clinical-trial registrations and FDA activity — hundreds of records — and brief the handful that actually move the pipeline. In plain language, with the source record one tap away.
See what's insideiPhone · English & 简体中文 · 7-day free trial
New phase 2 and phase 3 registrations — the asset, the sponsor, the population, and what would count as success.
Studies that just published outcomes to the registry, with the endpoints stated rather than spun.
New drug and biologic approvals and supplements, including priority review and orphan designations.
Drug recalls with their Class I–III severity, the recalling firm, and the stated reason.
| Source | Contributes |
|---|---|
| ClinicalTrials.gov | Trial registrations, phase 2/3 updates, results postings |
| openFDA · Drugs@FDA | Approvals, supplements, review priority, designations |
| openFDA · Enforcement | Drug recalls with severity classification |
| FDA Newsroom | Agency announcements and safety communications |
All four are public and authoritative. Summaries are AI-generated from those records, and every card links back to the original so you can check the claim yourself.